Circle Wealth Management LLC Trims Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Circle Wealth Management LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,681 shares of the medical equipment provider’s stock after selling 230 shares during the period. Circle Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,317,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Hantz Financial Services Inc. grew its stake in Intuitive Surgical by 4.9% in the third quarter. Hantz Financial Services Inc. now owns 14,143 shares of the medical equipment provider’s stock worth $6,948,000 after purchasing an additional 663 shares during the period. Northwest & Ethical Investments L.P. boosted its stake in Intuitive Surgical by 50.6% during the third quarter. Northwest & Ethical Investments L.P. now owns 15,741 shares of the medical equipment provider’s stock worth $7,733,000 after acquiring an additional 5,288 shares in the last quarter. Castle Hook Partners LP bought a new stake in Intuitive Surgical in the third quarter worth $53,126,000. Public Sector Pension Investment Board grew its stake in shares of Intuitive Surgical by 8.3% in the third quarter. Public Sector Pension Investment Board now owns 172,373 shares of the medical equipment provider’s stock worth $84,682,000 after acquiring an additional 13,150 shares during the last quarter. Finally, Fiduciary Trust Co increased its holdings in shares of Intuitive Surgical by 5.0% during the third quarter. Fiduciary Trust Co now owns 10,175 shares of the medical equipment provider’s stock valued at $4,999,000 after acquiring an additional 485 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 0.6 %

Intuitive Surgical stock opened at $542.00 on Friday. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $552.00. The company’s 50-day moving average price is $510.03 and its 200-day moving average price is $468.41. The company has a market cap of $193.05 billion, a PE ratio of 87.14, a price-to-earnings-growth ratio of 5.30 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Citigroup raised their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday. Piper Sandler restated an “overweight” rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $526.06.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,459 shares of company stock valued at $26,080,251. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.